Combination Treatment of Rituximab and Imatinib Mesylate for Simultaneous Relapse of MALT Lymphoma and a Gastrointestinal Stromal Tumor: Leukemia & Lymphoma: Vol 45, No 11

Views

CrossRef citations to date

Altmetric

Abstract

A clinical case of patient with a simultaneous gastrointestinal stromal tumors (GIST) and MALT lymphoma in relapse is presented. Simultaneous treatment with imatinib mesylate and rituximab was given, yielded response for both tumors and was well tolerated.

Keywords

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Combination Treatment of Rituximab and Imatinib Mesylate for Simultaneous Relapse of MALT Lymphoma and a Gastrointestinal Stromal Tumor

Information for

Open access

Opportunities

Help and information

Combination Treatment of Rituximab and Imatinib Mesylate for Simultaneous Relapse of MALT Lymphoma and a Gastrointestinal Stromal Tumor

Abstract

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature